Topics such as the pharmacovigilance and the involvement of patients in the Pharmacovigilance Risk Assessment Committee (PRAC) experience were presented, together with important projects like the European Patients??? Academy on Therapeutic Innovation (EUPATI) and Accelerated development of vaccine benefit-risk collaboration in Europe (ADVANCE).